Evidence map›Paper›PMID 39712912›Full record

ArticleEFSA journal. European Food Safety Authority2024

New approach methodologies for risk assessment using deep learning.

Enol Junquera, Irene Díaz, Susana Montes, Ferdinando Febbraio

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. New approach methodologies for risk assessment using deep learning.EFSA journal. European Food Safety Authority · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Enol JunqueraUniversity of Oviedo Oviedo Spain.
Irene DíazUniversity of Oviedo Oviedo Spain.
Susana MontesUniversity of Oviedo Oviedo Spain.
Ferdinando FebbraioInstitute of Biochemistry and Cell Biology National Research Council (CNR) Naples Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advancement of technologies and the development of more efficient artificial intelligence (AI) enable the processing of large amounts of data in a very short time. Concurrently, the increase in information within biological databases, such as 3D molecular structures or networks of functional macromolecule associations, will facilitate the creation of new methods for risk assessment that can serve as alternatives to animal testing. Specifically, the predictive capabilities of AI as new approach methodologies (NAMs) are poised to revolutionise risk assessment approaches. Our previous studies on molecular docking predictions, using the software Autodock Vina, indicated high-affinity binding of certain toxic chemicals to the 3D structures of human proteins associated with nervous and reproductive functions. Similar approaches revealed potential sublethal interactions of neonicotinoids with proteins linked to the bees' immune system. Building on these findings, we plan to develop an AI-based decision tool that exploits the data available on the toxicity of the most know chemical, such as LD50, and the data obtainable by their interaction with the human proteins to support risk assessment studies for multiple stressors still not characterised. Our focus will be on utilising these new bioinformatics methodologies to develop specific experimental designs that allow for confident and predictable study of the toxic and sublethal effects of pesticides on humans. We will also validate the developed NAMs by integrating existing in vivo information from scientific literature and technical reports. These approaches will significantly impact toxicity studies, guiding researchers' experiments and greatly reducing the need for animal testing.

Indexed as

artificial intelligencemolecular dockingmolecular stressorspesticide toxicityprotein 3D structurerisk assessmentsoftware development

Identifiers

PMID39712912
PMCPMC11659721

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.